New injection aims to boost Body's fight against hepatitis b
NCT ID NCT07190742
Summary
This study is testing whether a new injection called TVAX-008, when given alongside standard antiviral pills, can help people with chronic hepatitis B. The goal is to see if the combination can help patients achieve a key milestone called HBsAg negative status, which indicates better control of the virus. The trial will involve 80 adults who are already taking antiviral medication and will compare the new injection to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University first hospital
Beijing, 10000, China
Conditions
Explore the condition pages connected to this study.